Expectant management with selective delayed intervention for favorable-risk prostate cancer

被引：0

作者：

Klotz, L ^{[1
]}

机构：

[1] Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada

来源：

PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE | 2003年

关键词：

D O I：

暂无

中图分类号：

R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

摘要：

引用

页码：274 / 279

页数：6

共 50 条

[1] Expectant management with selective delayed intervention for favorable risk prostate cancer
Klotz, L
UROLOGIC ONCOLOGY, 2002, 7 (05): : 175 - 179
[2] Active surveillance with selective delayed intervention for favorable risk prostate cancer
Klotz, L
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (01) : 46 - 50
[3] Active Surveillance for Favorable-risk Prostate Cancer: Background, Patient Selection, Triggers for Intervention, and Outcomes
Klotz, Laurence
CURRENT UROLOGY REPORTS, 2012, 13 (02) : 153 - 159
[4] Thoughts on Criteria for Active Surveillance of Favorable-risk Prostate Cancer
Gettman, Matthew T.
EUROPEAN UROLOGY, 2016, 70 (06) : 961 - 962
[5] Active surveillance with selective delayed intervention for favorable risk prostate cancer: Updated experience with 500 patients
Klotz, LH
Loblaw, A
Holden, L
Morton, G
Nam, RK
Danjoux, C
JOURNAL OF UROLOGY, 2006, 175 (04): : 211 - 211
[6] Active Surveillance for Favorable-risk Prostate Cancer: Background, Patient Selection, Triggers for Intervention, and Outcomes
Laurence Klotz
Current Urology Reports, 2012, 13 : 153 - 159
[7] Active Surveillance for Favorable-Risk Prostate Cancer: A Short Review
Lawrentschuk, Nathan
Klotz, Laurence
KOREAN JOURNAL OF UROLOGY, 2010, 51 (10) : 665 - 670
[8] Active surveillance for favorable-risk prostate cancer: who, how and why?
Klotz, Laurence
NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (12): : 692 - 698
[9] Active surveillance for favorable-risk prostate cancer: who, how and why?
Laurence Klotz
Nature Clinical Practice Oncology, 2007, 4 : 692 - 698
[10] Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer
Kenfield S.A.
Chang S.T.
Chan J.M.
Current Treatment Options in Oncology, 2007, 8 (3) : 173 - 196

← 1 2 3 4 5 →